Beta Bionics Inc. (BBNX)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
18.8152 wk Range
8.80Overview - BBNX - Beta Bionics Inc.
Key Statistics
Valuation
Enterprise Value
629.53M
P/E (Trailing)
-9.77
P/E (Forward)
-8.18
PEG Ratio
-0.27
Price / Sales (TTM)
8.01
Price / Book
3.10
EV / EBITDA
-7.79
Profitability
Gross Margin
59.04%
Profit Margin
-61.31%
Operating Margin
-79.89%
Return on Assets
-16.67%
Return on Equity
-26.15%
Ownership
Shares Outstanding
44.98M
Float
31.15M
Short % of Shares Outstanding
11.25%
Held by Insiders
0.81%
Held by Institutions
112.86%
Price stats
50-Day Avg
18.73
200-Day Avg
15.46
Analyst Consensus
15 analysts
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BBNX - Beta Bionics Inc.
Peers - BBNX - Beta Bionics Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- BBNXNASDAQBeta Bionics Inc.954.30MMarket Cap-19.45%52-week change-9.77P/E (Trailing)-61.31%Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.32.50BMarket Cap-9.66%52-week change16.43P/E (Trailing)9.33%Profit Margin
- DXCMNASDAQDexCom Inc.32.44BMarket Cap+18.88%52-week change34.14P/E (Trailing)20.11%Profit Margin
- PODDNASDAQInsulet Corporation9.78BMarket Cap-131.64%52-week change26.42P/E (Trailing)12.29%Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.37%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corp.8.77BMarket Cap+32.91%52-week change74.88P/E (Trailing)-2.03%Profit Margin
- LIVNNASDAQLivaNova PLC4.45BMarket Cap+32.91%52-week change23.93P/E (Trailing)12.81%Profit Margin
Profile Summary - BBNX - Beta Bionics Inc.
About
Beta Bionics Inc. is a commercial-stage medical device company focused on automated insulin delivery for people with insulin-requiring diabetes. Its core product, the iLet Bionic Pancreas, is designed to simplify day-to-day diabetes management by using adaptive closed-loop algorithms to determine insulin dosing. Beta…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
